Which has grown faster, HCSG or RARE?

Over the past five years, RARE grew revenue faster — HCSG at a 2.29% CAGR versus RARE at 14.81%.

Is HCSG or RARE more profitable?

HCSG runs the higher net margin — HCSG at 6.59% versus RARE at -81.79%.

How have HCSG and RARE total returns compared?

Over the past 10 years, HCSG delivered -4.24% and RARE delivered -14.91% annualized total return. Past performance doesn't predict future results.

Healthcare Services Group, Inc. (HCSG) vs Ultragenyx Pharmaceutical Inc. (RARE)

A side-by-side comparison of Healthcare Services Group, Inc. and Ultragenyx Pharmaceutical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

HCSG

Healthcare Services Group, Inc.

$1.46B

$21.31HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT

RARE

Ultragenyx Pharmaceutical Inc.

$1.43B

$14.57HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

Total return — HCSG vs RARE

growth of $100 · dividends reinvested · last 10y

HCSG -35.3% (-4.3%/yr)RARE -79.2% (-14.5%/yr)HCSG compounded faster over this window

HCSG RARE

HCSG vs RARE: by the numbers

•HCSG is the larger company ($1.46B vs $1.43B market cap).
•HCSG is profitable (6.59% net margin) while RARE runs a net loss (-81.79%).
•RARE grew revenue faster over the past five years (14.81% vs 2.29% CAGR).

Metrics side by side

Valuation

Metric	HCSG	RARE
P/E ratio	12.46	N/A
Forward P/E	17.77	N/A
P/S ratio	0.78	2.00
P/B ratio	2.82	N/A
EV / EBITDA	9.02	N/A
FCF yield	10.36%	N/A

Profitability

Metric	HCSG	RARE
Gross margin	17.33%	83.12%
Operating margin	7.03%	-73.77%
Net margin	6.59%	-81.79%
ROE	23.70%	N/A
ROIC	16.83%	-53.48%

Growth (annualized)

Metric	HCSG	RARE
Revenue CAGR (5Y)	2.29%	14.81%
EPS CAGR (5Y)	-9.08%	N/A
FCF CAGR (5Y)	-8.15%	N/A
Total return CAGR (5Y)	-2.00%	-30.14%

Frequently asked

Which has grown faster, HCSG or RARE?: Over the past five years, RARE grew revenue faster — HCSG at a 2.29% CAGR versus RARE at 14.81%.
Is HCSG or RARE more profitable?: HCSG runs the higher net margin — HCSG at 6.59% versus RARE at -81.79%.
How have HCSG and RARE total returns compared?: Over the past 10 years, HCSG delivered -4.24% and RARE delivered -14.91% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HCSG analysis Full RARE analysis Interactive comparison tool

Dig into the metrics

Healthcare Services P/E ratio Healthcare Services ROE Ultragenyx Pharmaceutical ROE Healthcare Services operating margin Ultragenyx Pharmaceutical operating margin Healthcare Services revenue growth Ultragenyx Pharmaceutical revenue growth Healthcare Services free cash flow Ultragenyx Pharmaceutical free cash flow

Healthcare Services & Ultragenyx Pharmaceutical appear in these rankings

Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.